R&D, Reimbursement Impact Of Device Trial Data Bank Sought By FDA

FDA is seeking industry input on the potential impact on future R&D efforts of mandatory disclosure of device clinical trial data in a public database managed by the National Institutes of Health.

More from Archive

More from Medtech Insight